217 related articles for article (PubMed ID: 22163258)
41. Age-appropriate versus up-to-date coverage of routine childhood vaccinations among young children in Israel.
Stein-Zamir C; Israeli A
Hum Vaccin Immunother; 2017 Sep; 13(9):2102-2110. PubMed ID: 28696824
[TBL] [Abstract][Full Text] [Related]
42. [The German Standing Committee on Vaccination: organization and mode of functioning].
Harder T
Z Rheumatol; 2020 Nov; 79(9):839-847. PubMed ID: 32902696
[TBL] [Abstract][Full Text] [Related]
43. [Actual problems of vaccine prophylaxis in the Russian Federation].
Onishchenko GG; Ezhlova EB; Mel'nikova AA
Zh Mikrobiol Epidemiol Immunobiol; 2014; (1):9-19. PubMed ID: 24738288
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of the national immunisation programme in the Netherlands: immunity to diphtheria, tetanus, poliomyelitis, measles, mumps, rubella and Haemophilus influenzae type b.
de Melker HE; van den Hof S; Berbers GA; Conyn-van Spaendonck MA
Vaccine; 2003 Jan; 21(7-8):716-20. PubMed ID: 12531347
[TBL] [Abstract][Full Text] [Related]
45. [Preventive vaccinations in dentistry].
Rostetter C; Lübbers HT; Kruse AL; Metzler P
Swiss Dent J; 2015; 125(2):174-5. PubMed ID: 25734399
[TBL] [Abstract][Full Text] [Related]
46. Immunizations in immunocompromised patients: a guide for dermatologists.
Mohme S; Schmalzing M; Müller CSL; Vogt T; Goebeler M; Stoevesandt J
J Dtsch Dermatol Ges; 2020 Jul; 18(7):699-723. PubMed ID: 32713146
[TBL] [Abstract][Full Text] [Related]
47. Compulsory and recommended vaccination in Italy: evaluation of coverage and non-compliance between 1998-2002 in Northern Italy.
Stampi S; Ricci R; Ruffilli I; Zanetti F
BMC Public Health; 2005 Apr; 5():42. PubMed ID: 15845144
[TBL] [Abstract][Full Text] [Related]
48. How are children who are delayed in the Childhood Vaccination Programme vaccinated: A nationwide register-based cohort study of Danish children aged 15-24 months and semi-structured interviews with vaccination providers.
Pedersen KB; Holck ME; Jensen AKG; Suppli CH; Benn CS; Krause TG; Sørup S
Scand J Public Health; 2020 Feb; 48(1):96-105. PubMed ID: 30024308
[No Abstract] [Full Text] [Related]
49. A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK.
Marlow R; Kuriyakose S; Mesaros N; Han HH; Tomlinson R; Faust SN; Snape MD; Pollard AJ; Finn A
Vaccine; 2018 Apr; 36(17):2300-2306. PubMed ID: 29576304
[TBL] [Abstract][Full Text] [Related]
50. Extension of French vaccination mandates: from the recommendation of the Steering Committee of the Citizen Consultation on Vaccination to the law.
Lévy-Bruhl D; Desenclos JC; Quelet S; Bourdillon F
Euro Surveill; 2018 Apr; 23(17):. PubMed ID: 29717696
[TBL] [Abstract][Full Text] [Related]
51. [Vaccination coverage of children and adolescents in Germany: New data from KiGGS Wave 2 and trends from the KiGGS study].
Poethko-Müller C; Kuhnert R; Gillesberg Lassen S; Siedler A
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2019 Apr; 62(4):410-421. PubMed ID: 30788538
[TBL] [Abstract][Full Text] [Related]
52. Maternal pertussis vaccination and its effects on the immune response of infants aged up to 12 months in the Netherlands: an open-label, parallel, randomised controlled trial.
Barug D; Pronk I; van Houten MA; Versteegh FGA; Knol MJ; van de Kassteele J; Berbers GAM; Sanders EAM; Rots NY
Lancet Infect Dis; 2019 Apr; 19(4):392-401. PubMed ID: 30938299
[TBL] [Abstract][Full Text] [Related]
53. [The need for preventive vaccination of children and adolescents in highly civilized industrial countries].
Scheier R
Offentl Gesundheitswes; 1989; 51(8-9):483-7. PubMed ID: 2531336
[TBL] [Abstract][Full Text] [Related]
54. [Vaccination schedule, present and future].
Bégué P
Rev Prat; 1990 Dec; 40(28):2613-6. PubMed ID: 2281264
[TBL] [Abstract][Full Text] [Related]
55. Adult immunizations: update on recommendations.
Pham H; Geraci SA; Burton MJ;
Am J Med; 2011 Aug; 124(8):698-701. PubMed ID: 21658665
[TBL] [Abstract][Full Text] [Related]
56. Immunity against measles, mumps, rubella, varicella, diphtheria, tetanus, polio, hepatitis A and hepatitis B among adult asylum seekers in the Netherlands, 2016.
Freidl GS; Tostmann A; Curvers M; Ruijs WLM; Smits G; Schepp R; Duizer E; Boland G; de Melker H; van der Klis FRM; Hautvast JLA; Veldhuijzen IK
Vaccine; 2018 Mar; 36(12):1664-1672. PubMed ID: 29454516
[TBL] [Abstract][Full Text] [Related]
57. The immunomodulatory effects of measles-mumps-rubella vaccination on persistence of heterologous vaccine responses.
Zimmermann P; Perrett KP; van der Klis FR; Curtis N
Immunol Cell Biol; 2019 Jul; 97(6):577-585. PubMed ID: 30791143
[TBL] [Abstract][Full Text] [Related]
58. [Vaccinations in dentistry. An update].
Swiss Dent J; 2015; 125(3):328-9. PubMed ID: 26168689
[TBL] [Abstract][Full Text] [Related]
59. [Preventive vaccinations for medical personnel].
Kerwat K; Goedecke M; Wulf H
Anasthesiol Intensivmed Notfallmed Schmerzther; 2014 May; 49(5):310-2. PubMed ID: 24863331
[TBL] [Abstract][Full Text] [Related]
60. [Implementation of seasonal influenza and human papillomavirus vaccination recommendations in gynecological practices in Germany].
Bödeker B; Seefeld L; Buck S; Ommen O; Wichmann O
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2016 Mar; 59(3):396-404. PubMed ID: 26753868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
